Last Updated 00:00:00
longbridge loading
Company Encyclopedia
name
Xintian Pharma
002873.SZ
Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, and blood-tonifying remedies. The company also engages in research and development; consulting; scientific research; accommodation and catering; technology promotion; pharmaceutical research and development; and health food processing activities.
2.805 T
002873.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking168/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.68%D
    • Profit Margin1.15%C
    • Gross Margin72.49%A
  • Growth ScoreD
    • Revenue YoY-15.82%E
    • Net Profit YoY-79.43%E
    • Total Assets YoY9.09%B
    • Net Assets YoY5.07%C
  • Cash ScoreC
    • Cash Flow Margin1322.78%A
    • OCF YoY-15.82%E
  • Operating ScoreC
    • Turnover0.37C
  • Debt ScoreB
    • Gearing Ratio39.78%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --